Zoetis Inc. (NYSE:ZTS) Receives $212.13 Consensus Target Price from Brokerages

Zoetis Inc. (NYSE:ZTS) has been given an average rating of “Buy” by the ten research firms that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating on the company. The average 12 month price objective among brokers that have covered the stock in the last year is $212.13.

Several analysts recently commented on the company. UBS Group cut their price objective on Zoetis from $189.00 to $170.00 and set a “neutral” rating for the company in a report on Wednesday, May 7th. Piper Sandler lifted their price objective on Zoetis from $205.00 to $210.00 and gave the stock an “overweight” rating in a report on Monday, May 12th. Finally, Stifel Nicolaus lowered Zoetis from a “buy” rating to a “hold” rating and cut their price objective for the stock from $165.00 to $160.00 in a report on Wednesday, June 18th.

Zoetis Stock Up 0.5%

Zoetis stock opened at $155.68 on Tuesday. The firm has a market cap of $69.31 billion, a price-to-earnings ratio of 27.95, a PEG ratio of 2.57 and a beta of 0.91. The stock has a fifty day simple moving average of $161.27 and a two-hundred day simple moving average of $161.75. Zoetis has a 12 month low of $139.70 and a 12 month high of $200.33. The company has a current ratio of 1.74, a quick ratio of 1.04 and a debt-to-equity ratio of 1.12.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, May 6th. The company reported $1.48 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.08. The business had revenue of $2.22 billion during the quarter, compared to analyst estimates of $2.20 billion. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The company’s quarterly revenue was up 1.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.38 EPS. Equities analysts predict that Zoetis will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.28%. The ex-dividend date of this dividend is Friday, July 18th. Zoetis’s dividend payout ratio is presently 35.91%.

Insider Transactions at Zoetis

In other news, EVP Roxanne Lagano sold 652 shares of the business’s stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total value of $110,840.00. Following the transaction, the executive vice president directly owned 15,129 shares in the company, valued at $2,571,930. The trade was a 4.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.16% of the company’s stock.

Hedge Funds Weigh In On Zoetis

Several large investors have recently made changes to their positions in the business. Vanguard Group Inc. lifted its position in shares of Zoetis by 0.5% in the first quarter. Vanguard Group Inc. now owns 41,556,164 shares of the company’s stock valued at $6,842,222,000 after acquiring an additional 189,287 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Zoetis by 1.8% in the fourth quarter. Geode Capital Management LLC now owns 10,617,897 shares of the company’s stock valued at $1,726,075,000 after acquiring an additional 190,137 shares in the last quarter. Polen Capital Management LLC lifted its position in shares of Zoetis by 17.6% in the first quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock valued at $1,448,401,000 after acquiring an additional 1,313,653 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of Zoetis by 78.5% in the fourth quarter. Wellington Management Group LLP now owns 6,958,543 shares of the company’s stock valued at $1,133,755,000 after acquiring an additional 3,059,255 shares in the last quarter. Finally, Northern Trust Corp lifted its position in shares of Zoetis by 1.2% in the first quarter. Northern Trust Corp now owns 6,504,902 shares of the company’s stock valued at $1,071,032,000 after acquiring an additional 78,508 shares in the last quarter. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.